Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Scientists and ethicists approve of a ban and say it will foster societal consensus

Terry Kaan, Vicki Xafis, Owen Schaefer Et al. 11-17-2021 [Kaan is affiliated with The University of Hong Kong, China; Xafis is affiliated with the National University of Singapore and a Journal of Medical Ethics resercher; Schaefer is an Assistant Professor of the Centre for Biomedical Ethics, Yong Loo Lin School of Medicine], “Germline genome editing: Moratorium, hard law, or an informed adaptive consensus,” https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1009742 Cut By: m.jam

To begin with, there should be a fixed period during which no clinical uses of germline editing whatsoever are allowed. As well as allowing for discussions about the technical, scientific, medical, societal, ethical and moral issues that must be considered before germline editing is permitted, this period would provide time to establish an international framework. Thereafter, nations may choose to follow separate paths. About 30 nations currently have legislation that directly or indirectly bars all clinical uses of germline editing, and they might choose to continue the moratorium indefinitely or implement a permanent ban. However, any nation could also choose to allow specific applications of germline editing, provided that it first: gives public notice of its intention to consider the application and engages for a defined period in international consultation about the wisdom of doing so; determines through transparent evaluation that the application is justified; and ascertains that there is broad societal consensus in the nation about the appropriateness of the application. Nations might well choose different paths, but they would agree to proceed openly and with due respect to the opinions of humankind on an issue that will ultimately affect the entire species. To be clear, our proposed moratorium does not apply to germline editing for research uses, provided that these studies do not involve the transfer of an embryo to a person’s uterus. It also does not apply to genome editing in human somatic (non-reproductive) cells to treat diseases, for which patients can provide informed consent and the DNA modifications are not heritable. The 18 signatories of this call include scientists and ethicists who are citizens of 7 countries. Many of us have been involved in the gene-editing field by developing and applying the technology, organizing and speaking at international summits, serving on national advisory committees and studying the ethical issues raised.

Sign in to recut, update, or save this card.